Source 1primary paper2025MED
Toolkit/chGFE3
chGFE3
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Finally, we developed a chemically inducible version of GFE3, chGFE3, which degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
Usefulness & Problems
Why this is useful
chGFE3 is a chemically inducible version of GFE3 for ablating inhibitory synapses. Its activity depends on combination with a HaloTag ligand-trimethoprim dimerizer.; chemically inducible ablation of inhibitory synapses; manipulating neural circuit structure with chemical control
Source:
chGFE3 is a chemically inducible version of GFE3 for ablating inhibitory synapses. Its activity depends on combination with a HaloTag ligand-trimethoprim dimerizer.
Source:
chemically inducible ablation of inhibitory synapses
Source:
manipulating neural circuit structure with chemical control
Problem solved
It provides chemical control over inhibitory synapse ablation, expanding structural circuit manipulation beyond constitutive tools.; adds chemical inducibility to inhibitory synapse ablation
Source:
It provides chemical control over inhibitory synapse ablation, expanding structural circuit manipulation beyond constitutive tools.
Source:
adds chemical inducibility to inhibitory synapse ablation
Problem links
adds chemical inducibility to inhibitory synapse ablation
LiteratureIt provides chemical control over inhibitory synapse ablation, expanding structural circuit manipulation beyond constitutive tools.
Source:
It provides chemical control over inhibitory synapse ablation, expanding structural circuit manipulation beyond constitutive tools.
Published Workflows
Objective: Develop a toolbox of genetically encoded synapse ablation tools for manipulating neural circuit structure by degrading synaptic scaffolding proteins at excitatory and inhibitory synapses, including constitutive, light-inducible, and chemically inducible variants.
Why it works: The workflow is based on rationally designing genetically encoded constructs that recruit degradation machinery to synaptic scaffolding proteins, so scaffold loss leads to functional synapse ablation.
E3 ligase-dependent degradation of synaptic scaffolding proteinsPSD-95-directed excitatory synapse ablationGephyrin-directed inhibitory synapse ablationrational designoptogenetic inductionchemogenetic induction
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Techniques
Computational DesignTarget processes
degradationInput: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenoperating role: regulatorswitch architecture: cleavageswitch architecture: multi componentswitch architecture: recruitment
The abstract supports a requirement for genetic expression of chGFE3 and addition of the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.; requires combination with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim
Uses more than one coordinated component. Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. Multi-component delivery and stoichiometry control can make deployment harder. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
chGFE3 is a chemically inducible GFE3 variant that degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
we developed a chemically inducible version of GFE3, chGFE3, which degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
paGFE3 is a light-inducible GFE3 variant based on a PhoCl2c photoactivatable complex that degrades Gephyrin and ablates inhibitory synapses in response to 400 nm light.
we developed a light-inducible version of GFE3, paGFE3, using a novel photoactivatable complex based on the photocleavable protein PhoCl2c. paGFE3 degrades Gephyrin and ablates inhibitory synapses in response to 400 nm light.
activation wavelength 400 nm
PFE3 targets Mdm2 RING and Protocadherin 10 proteasome-interacting functions to PSD-95, leading to efficient ablation of excitatory synapses.
PFE3 targets the RING domain of the E3 ligase Mdm2 and the proteasome-interacting region of Protocadherin 10 to the scaffolding protein PSD-95, leading to efficient ablation of excitatory synapses.
Each of the three synapse ablation tools is specific, reversible, and capable of breaking neural circuits at precise locations.
Each tool is specific, reversible, and capable of breaking neural circuits at precise locations.
The paper introduces three rationally designed genetically encoded tools that use E3 ligase-dependent mechanisms to degrade synaptic scaffolding proteins and thereby functionally ablate synapses.
Here, we introduce three rationally designed genetically encoded tools that use E3 ligase-dependent mechanisms to trigger the degradation of synaptic scaffolding proteins, leading to functional ablation of synapses.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug chgfe3
Finally, we developed a chemically inducible version of GFE3, chGFE3, which degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
Source:
mechanism of actionsupports
chGFE3 is a chemically inducible GFE3 variant that degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
we developed a chemically inducible version of GFE3, chGFE3, which degrades inhibitory synapses when combined with the bio-orthogonal dimerizer HaloTag ligand-trimethoprim.
Source:
performance summarysupports
Each of the three synapse ablation tools is specific, reversible, and capable of breaking neural circuits at precise locations.
Each tool is specific, reversible, and capable of breaking neural circuits at precise locations.
Source:
tool introductionsupports
The paper introduces three rationally designed genetically encoded tools that use E3 ligase-dependent mechanisms to degrade synaptic scaffolding proteins and thereby functionally ablate synapses.
Here, we introduce three rationally designed genetically encoded tools that use E3 ligase-dependent mechanisms to trigger the degradation of synaptic scaffolding proteins, leading to functional ablation of synapses.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Source:
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Source-backed strengths
genetically encoded; specific; reversible; capable of breaking neural circuits at precise locations
Source:
genetically encoded
Source:
specific
Source:
reversible
Source:
capable of breaking neural circuits at precise locations
Compared with paGFE3
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Shared frame: source-stated alternative in extracted literature
Strengths here: genetically encoded; specific; reversible.
Source:
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Compared with PFE3
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Shared frame: source-stated alternative in extracted literature
Strengths here: genetically encoded; specific; reversible.
Source:
The abstract contrasts chGFE3 with light-inducible paGFE3 and constitutive PFE3, and identifies it as another inducible version of GFE3.
Ranked Citations
- 1.